文献速递腹部技术与安全US

口服纤维素类对比剂经腹超声在胃溃疡检出和监测中的评估

Evaluation of Transabdominal Ultrasound with Oral Cellulose-Based Contrast Agent in the Detection and Surveillance of Gastric Ulcer.
PubMed 文献 · Ultrasound Med Biol · 2017-04-28

本研究纳入124例经胃镜和活检确诊的良性胃溃疡患者,评估口服纤维素类对比剂经腹超声(TUS-OCCA)的检出和监测作用。TUS-OCCA检出率为76%(94/124),对≤5mm、5-10mm、10-15mm和>15mm病变的检出率分别为32%、77%、96%和100%。系列TUS-OCCA可用于可检出胃溃疡常规治疗期间的密切监测,并指导额外干预。

要点

  • TUS-OCCA对胃溃疡总检出率为76%,病变>10mm时检出率≥96%。
  • 病变≤5mm检出率仅32%,胃窦部检出率70%低于胃角84%和胃体85%。
  • 系列TUS-OCCA可监测溃疡愈合,并有助于发现初诊活检误诊为良性的胃癌。

核心结论

  • 系列TUS-OCCA可用于TUS-OCCA可检出的胃溃疡常规治疗期间的密切监测,监测可指导额外干预;基于TUS-OCCA的无创随访方案有助于检出初诊内镜活检误诊为良性溃疡的胃癌。

研究设计与样本

  • 单中心研究,纳入124例经胃镜和活检确诊的良性胃溃疡连续患者,采用口服纤维素类对比剂经腹超声(TUS-OCCA)系列检查(约每2周1次)监测治疗效果。

诊断标准与关键数值

  • TUS-OCCA对胃溃疡的总检出率为76%(94/124)。
  • 对≤5mm病变检出率为32%(10/31),5-10mm为77%(27/35),10-15mm为96%(25/26),>15mm为100%(32/32)。
  • 对胃窦、胃角、胃体病变的检出率分别为70%、84%、85%。
  • 30例未检出病变大小为2-13mm,其中胃窦11例、胃角9例、胃体3例、贲门6例、胃底1例。

临床应用与阅片要点

  • TUS-OCCA系列检查(约每2周1次)可用于TUS-OCCA可检出胃溃疡的常规治疗监测,并根据结果计划额外干预;监测有助于发现初诊内镜活检误诊为良性溃疡的胃癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The aim of this study was to assess the role of transabdominal ultrasound with cellulose-based oral contrast agent (TUS-OCCA) in the detection and surveillance of gastric ulcer. The study was approved by the institutional review board at Shengjing Hospital of China Medical University. A total of 124 consecutive patients with benign gastric ulcer diagnosed by gastroscopy and biopsy were enrolled. Serial TUS-OCCA (approximately 1 exam every 2 wk) was performed to monitor the effects of treatment, and additional interventions were planned according to the results. TUS-OCCA detected gastric ulcer in 76% of patients (94 of 124). The detection rates for lesions of ≤5 mm, lesions of 5-10 mm, lesions of 10-15 mm and lesions >15 mm were 32% (10 of 31), 77% (27 of 35), 96% (25 of 26) and 100% (32 of 32), respectively. The detection rates for lesions located in the antrum, angle and body were 70%, 84% and 85%, respectively. Among 30 undetected lesions, which ranged 2-13 mm in size, 11 were at the antrum, 9 at the angle, 3 in the body, 6 at the cardia and 1 at the fundus. During the follow-up period, patients underwent a mean of 3.8 TUS-OCCA examinations (range 2-7), and ulcers were healed after 8 wk (range 2-12 wk) of standard therapy in 76 patients. Eighteen patients who did not show improvement after standard therapy underwent repeat gastroscopy with biopsy. Repeat biopsy was positive for gastric cancer in 4 of these: 2 of the remaining 14 were diagnosed with gastric cancer at gastrectomy, and 12 were diagnosed with chronic benign ulcer. These results indicate that serial TUS-OCCA can be used for close monitoring during routine treatment of gastric ulcers that are detectable by TUS-OCCA and that monitoring by TUS-OCCA can guide additional interventions. A non-invasive follow-up program based on TUS-OCCA can also help to detect gastric cancers that have been misdiagnosed as benign ulcers at the initial endoscopic biopsy.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Liu Z, Guo J, Wang S, et al. Evaluation of Transabdominal Ultrasound with Oral Cellulose-Based Contrast Agent in the Detection and Surveillance of Gastric Ulcer. Ultrasound Med Biol. 2017. PMID: 28461064. doi:10.1016/j.ultrasmedbio.2017.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。